New imaging technique could personalize radiation for esophageal cancer

NCT ID NCT04846309

Recruiting now Disease control Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 07, 2026 · Last updated Jun 16, 2026 · Updated 2 times

Summary

This early-stage trial tests whether using special scans (FMISO-PET and MRI) to find low-oxygen areas in esophageal tumors can help doctors give a higher, more effective radiation dose to those areas while keeping standard treatment for others. The study involves 16 adults with esophageal cancer who are already scheduled for chemotherapy and radiation. The main goal is to check safety, but researchers will also track how well the cancer responds and how long it stays under control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Huntsman Cancer Institute
RECRUITING

Salt Lake City, Utah, 84112, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

ESOPHAGEAL CANCER